According to the American Liver Foundation, more than 25 million Americans are afflicted with liver and gallbladder disease and more than 43,000 die of liver disease each year. While several factors contribute to liver damage, viral hepatitis is the single most important cause of liver disease in the United States and worldwide. Roughly 200 million people worldwide are infected with the Hepatitis C virus (HCV). 4.9 million of those are in the United States (estimates go as high as 15 million) and 5 million in Western Europe. For every one person infected with the AIDS virus, there are more than four infected with Hepatitis C. There are up to 230,000 new hepatitis C infections in the U.S. every year. Currently, 8,000 to 10,000 deaths each year are a result of HCV. Within the next 10-20 years, chronic hepatitis C is predicted to become a major burden on the health care system as patients with no symptoms progress to end-stage liver disease and develop hepatocellular carcinoma. Predictions in the USA suggest that there will be a 60% increase in the incidence of cirrhosis, a 68% increase in hematoma incidence, a 528% increase in the need for transplantation, and a 223% increase in liver death rate. Lavegajerez
The roles of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in causing hepatocellular carcinoma (HCC) are well documented. The frequency of HCC correlates with chronic HBV infection rates. HCC is a cancer arising from the liver. It is also known as primary liver cancer or hematoma. HCC is the fifth most common cancer in the world and the majority of patients with HCC will die within one year because of the cancer. The majority of primary liver cancers (over 90 to 95 %) arises from liver cells and is called hepatocellular cancer or carcinoma. In 1990, the World Health Organization estimated that there were about 430,000 new cases of HCC worldwide, and a similar number of patients died resulting from this disease. Moreover, recent data show that the frequency of HCC in the U.S. overall is rising. Is there a way to curb this rise? Lavegajerez While there is no cure for hepatitis and no completely effective treatment, the threats resulting from HCC, cirrhosis, and various hepatitis strands may best be combated by supporting the liver with natural supplements.This extremely effective combination of ingredients has Double Blind Studies verifying decreases in degenerative liver damage in patients with chronic liver disease (cirrhosis of the liver) in as few as 30 to 90 days. This combination has proven studies for detoxifying the liver, normalizing liver metabolism and preventing further liver damage due to internal and external toxins like alcohol, cigarettes, long term pharmaceutical use, and environmental poisons
Leave a Reply